Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
123,850,680
-
Number of holders
-
87
-
Total 13F shares, excl. options
-
61,703,860
-
Shares change
-
+54,562,362
-
Total reported value, excl. options
-
$2,318,551,779
-
Value change
-
+$2,050,102,770
-
Number of buys
-
86
-
Price
-
$37.59
Significant Holders of Guardant Health, Inc. - Common Stock (GH) as of Q4 2018
87 filings reported holding GH - Guardant Health, Inc. - Common Stock as of Q4 2018.
Guardant Health, Inc. - Common Stock (GH) has 87 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 61,703,860 shares
of 123,850,680 outstanding shares and own 50% of the company stock.
Largest 10 shareholders include SB INVESTMENT ADVISERS (UK) LTD (25,816,470 shares), SC US (TTGP), LTD. (7,784,052 shares), VK Services, LLC (7,141,498 shares), MORGAN STANLEY (2,115,741 shares), SOFTBANK GROUP CORP (2,033,990 shares), Temasek Holdings (Private) Ltd (1,613,007 shares), ORBIMED ADVISORS LLC (1,534,464 shares), PRICE T ROWE ASSOCIATES INC /MD/ (1,406,296 shares), FRANKLIN RESOURCES INC (1,219,948 shares), and Vanguard Group Inc (1,133,455 shares).
This table shows the top 87 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.